ArticleScience advances2023

A rationally designed ICAM1 antibody drug conjugate eradicates late-stage and refractory triple-negative breast tumors in vivo.

Peng Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.